Overexpression of CD300A inhibits progression of NSCLC through downregulating Wnt/β-catenin pathway

Overview of attention for article published in OncoTargets and therapy, December 2018

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 6 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 488 followers.

Overexpression of CD300A inhibits progression of NSCLC through downregulating Wnt/β-catenin pathway.: Related Articles Overexpression of CD300A inhibits progression of NSCLC through downregulating Wnt/β-catenin pathway. Onco Targets Ther.… https://t.co/Nhh

23 Dec 2018

Reply Repost Favourite

Dove Medical Press

Article Metrics

Overexpression of CD300A inhibits progression of NSCLC through downregulating Wnt/β-catenin pathway

Mentioned by

Citations

Readers on